Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
RSS SUMMARY · AGGREGATED FROM CNBC
New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.
New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.
New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Micron and Qualcomm are among the most overbought stocks this week. Here are the others
CNBC·11h ago·3 min read
Health
MV Hondius hantavirus outbreak: A luxury expedition cruise boom and new world of remote travel risks
CNBC·11h ago·3 min read
Business
Why one of the nation’s largest auto lenders isn’t worried about high vehicle prices or ‘forever loans’
CNBC·12h ago·3 min read
US
U.S. sanctions companies and individuals in the Middle East and China for helping Iran
CNBC·14h ago·3 min read
Related
On this beat
Health
Passengers on Hantavirus Cruise Ship Will Disembark in Tenerife and Return to Home Countries
TNYT·5h ago·3 min read
Health
WHO director says he will personally oversee hantavirus cruise evacuation
CBS NEWS·9h ago·3 min read
Health
Hantavirus Vaccines and Treatments Are in the Pipeline
TNYT·10h ago·3 min read
Health
If you find yourself walking more slowly than you used to, it might be time to get your hearing checked, writes @juliejargon. A study revealed a correlation that could affect your future well-being.
TWSJ·11h ago·3 min read